Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
int-snw-122622 | chia-screen-data-Fav | 2.870 | 6.90e-16 | 3.15e-04 | 2.50e-03 | 16 | 12 |
reg-snw-5682 | chia-screen-data-Fav | 2.230 | 2.01e-07 | 3.88e-02 | 2.97e-02 | 13 | 8 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
MED19 | 219541 | 4 | -2.657 | 3.449 | 115 | Yes | - |
KARS | 3735 | 2 | -1.759 | 2.428 | 123 | - | - |
CENPA | 1058 | 5 | -2.185 | 2.393 | 205 | Yes | - |
PHB2 | 11331 | 6 | -2.236 | 2.994 | 151 | Yes | - |
PHB | 5245 | 12 | -2.743 | 2.689 | 163 | Yes | Yes |
PSMA1 | 5682 | 2 | -1.363 | 2.230 | 29 | - | - |
YAP1 | 10413 | 12 | -4.256 | 3.538 | 53 | Yes | - |
POU5F1 | 5460 | 12 | -5.148 | 3.538 | 179 | Yes | Yes |
GTF2A2 | 2958 | 2 | -1.938 | 2.377 | 41 | - | - |
HAGH | 3029 | 2 | -1.562 | 2.870 | 32 | - | - |
ADSSL1 | 122622 | 2 | -1.224 | 2.870 | 36 | - | - |
SON | 6651 | 2 | -3.844 | 3.108 | 9 | Yes | Yes |
PSMD2 | 5708 | 6 | -4.172 | 3.157 | 389 | Yes | Yes |
LUC7L3 | 51747 | 4 | -3.523 | 3.449 | 18 | Yes | - |
COPS3 | 8533 | 5 | -1.873 | 2.435 | 118 | - | - |
POLR2E | 5434 | 5 | -2.037 | 2.644 | 316 | Yes | - |
GSPT1 | 2935 | 7 | -2.313 | 2.503 | 47 | Yes | Yes |
HSPD1 | 3329 | 2 | -1.852 | 2.870 | 325 | - | - |
HNRNPU | 3192 | 12 | -2.869 | 2.644 | 172 | Yes | - |
EIF2B3 | 8891 | 5 | -2.546 | 2.435 | 13 | Yes | Yes |
GPS1 | 2873 | 10 | -3.621 | 2.689 | 62 | Yes | Yes |
CDK12 | 51755 | 2 | -2.714 | 2.944 | 15 | Yes | - |
DDIT3 | 1649 | 11 | -2.825 | 3.504 | 343 | Yes | Yes |
PRPF40A | 55660 | 4 | -1.511 | 2.307 | 305 | - | - |
SF3A1 | 10291 | 2 | -2.787 | 3.129 | 51 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
PSMA1 | 5682 | COPS3 | 8533 | pd | < | reg.ITFP.txt: no annot |
GPS1 | 2873 | PHB | 5245 | pd | > | reg.ITFP.txt: no annot |
PHB | 5245 | ADSSL1 | 122622 | pp | -- | int.I2D: YeastMedium |
SON | 6651 | PRPF40A | 55660 | pp | -- | int.I2D: BIND, MINT, HPRD; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
CDK12 | 51755 | PRPF40A | 55660 | pp | -- | int.I2D: BioGrid, BIND, MINT, Pawson1, HPRD; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
POLR2E | 5434 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
HSPD1 | 3329 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
HSPD1 | 3329 | ADSSL1 | 122622 | pp | -- | int.I2D: IntAct_Yeast |
KARS | 3735 | PSMA1 | 5682 | pd | > | reg.ITFP.txt: no annot |
GSPT1 | 2935 | KARS | 3735 | pd | < | reg.ITFP.txt: no annot |
HSPD1 | 3329 | PRPF40A | 55660 | pd | < | reg.ITFP.txt: no annot |
PHB | 5245 | PHB2 | 11331 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast, IntAct_Yeast |
KARS | 3735 | PHB | 5245 | pd | > | reg.ITFP.txt: no annot |
KARS | 3735 | PHB2 | 11331 | pd | > | reg.ITFP.txt: no annot |
KARS | 3735 | PHB2 | 11331 | pp | -- | int.I2D: BioGrid_Yeast |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
LUC7L3 | 51747 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
GTF2A2 | 2958 | PSMA1 | 5682 | pd | > | reg.ITFP.txt: no annot |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
KARS | 3735 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
DDIT3 | 1649 | HSPD1 | 3329 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
PHB2 | 11331 | ADSSL1 | 122622 | pp | -- | int.I2D: YeastMedium |
GPS1 | 2873 | COPS3 | 8533 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: HPRD, IntAct, INNATEDB, BioGrid, MGI; int.HPRD: in vitro, yeast 2-hybrid |
POLR2E | 5434 | PRPF40A | 55660 | pd | <> | reg.ITFP.txt: no annot |
HNRNPU | 3192 | PRPF40A | 55660 | pd | < | reg.ITFP.txt: no annot |
HNRNPU | 3192 | PRPF40A | 55660 | pp | -- | int.I2D: BioGrid, Pawson1 |
CENPA | 1058 | KARS | 3735 | pd | <> | reg.ITFP.txt: no annot |
COPS3 | 8533 | EIF2B3 | 8891 | pd | > | reg.ITFP.txt: no annot |
PSMD2 | 5708 | ADSSL1 | 122622 | pp | -- | int.I2D: BioGrid_Yeast |
PSMA1 | 5682 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast |
HAGH | 3029 | ADSSL1 | 122622 | pp | -- | int.I2D: YeastLow |
PSMA1 | 5682 | PRPF40A | 55660 | pd | < | reg.ITFP.txt: no annot |
HSPD1 | 3329 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
GPS1 | 2873 | PHB2 | 11331 | pd | > | reg.ITFP.txt: no annot |
HNRNPU | 3192 | POLR2E | 5434 | pd | < | reg.ITFP.txt: no annot |
GTF2A2 | 2958 | PRPF40A | 55660 | pd | <> | reg.ITFP.txt: no annot |
PRPF40A | 55660 | ADSSL1 | 122622 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, IntAct_Yeast |
SF3A1 | 10291 | PRPF40A | 55660 | pp | -- | int.I2D: BioGrid, Pawson1; int.Mint: MI:0915(physical association) |
PSMD2 | 5708 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0008380 | RNA splicing | 4.14e-08 | 6.76e-04 | 4.300 | 7 | 14 | 232 |
GO:0005654 | nucleoplasm | 2.19e-07 | 3.58e-03 | 2.713 | 11 | 31 | 1095 |
GO:0005515 | protein binding | 2.59e-07 | 4.23e-03 | 1.229 | 22 | 77 | 6127 |
GO:0010467 | gene expression | 3.51e-07 | 5.72e-03 | 3.135 | 9 | 27 | 669 |
GO:0016032 | viral process | 1.19e-05 | 1.95e-01 | 3.081 | 7 | 16 | 540 |
GO:0005634 | nucleus | 1.44e-05 | 2.35e-01 | 1.283 | 18 | 55 | 4828 |
GO:0010388 | cullin deneddylation | 8.06e-05 | 1.00e+00 | 7.181 | 2 | 5 | 9 |
GO:0006397 | mRNA processing | 1.18e-04 | 1.00e+00 | 3.950 | 4 | 6 | 169 |
GO:0044212 | transcription regulatory region DNA binding | 1.24e-04 | 1.00e+00 | 3.933 | 4 | 5 | 171 |
GO:0016607 | nuclear speck | 1.35e-04 | 1.00e+00 | 3.899 | 4 | 6 | 175 |
GO:0044822 | poly(A) RNA binding | 1.39e-04 | 1.00e+00 | 2.276 | 8 | 27 | 1078 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1.74e-04 | 1.00e+00 | 6.650 | 2 | 2 | 13 |
GO:0005829 | cytosol | 7.29e-04 | 1.00e+00 | 1.487 | 11 | 38 | 2562 |
GO:0042594 | response to starvation | 1.09e-03 | 1.00e+00 | 5.351 | 2 | 3 | 32 |
GO:0008180 | COP9 signalosome | 1.23e-03 | 1.00e+00 | 5.263 | 2 | 6 | 34 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.51e-03 | 1.00e+00 | 3.707 | 3 | 4 | 150 |
GO:0006430 | lysyl-tRNA aminoacylation | 1.53e-03 | 1.00e+00 | 9.351 | 1 | 1 | 1 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 1.53e-03 | 1.00e+00 | 9.351 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 1.53e-03 | 1.00e+00 | 9.351 | 1 | 1 | 1 |
GO:0048291 | isotype switching to IgG isotypes | 1.53e-03 | 1.00e+00 | 9.351 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 1.53e-03 | 1.00e+00 | 9.351 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 1.53e-03 | 1.00e+00 | 9.351 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 1.53e-03 | 1.00e+00 | 9.351 | 1 | 1 | 1 |
GO:0004824 | lysine-tRNA ligase activity | 1.53e-03 | 1.00e+00 | 9.351 | 1 | 1 | 1 |
GO:0002368 | B cell cytokine production | 1.53e-03 | 1.00e+00 | 9.351 | 1 | 1 | 1 |
GO:0042981 | regulation of apoptotic process | 1.54e-03 | 1.00e+00 | 3.697 | 3 | 3 | 151 |
GO:0003723 | RNA binding | 1.94e-03 | 1.00e+00 | 2.879 | 4 | 15 | 355 |
GO:0000398 | mRNA splicing, via spliceosome | 1.98e-03 | 1.00e+00 | 3.569 | 3 | 9 | 165 |
GO:0006521 | regulation of cellular amino acid metabolic process | 2.64e-03 | 1.00e+00 | 4.707 | 2 | 2 | 50 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.70e-03 | 1.00e+00 | 3.412 | 3 | 5 | 184 |
GO:0006986 | response to unfolded protein | 2.74e-03 | 1.00e+00 | 4.678 | 2 | 2 | 51 |
GO:0060242 | contact inhibition | 3.06e-03 | 1.00e+00 | 8.351 | 1 | 1 | 2 |
GO:0004019 | adenylosuccinate synthase activity | 3.06e-03 | 1.00e+00 | 8.351 | 1 | 1 | 2 |
GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain | 3.06e-03 | 1.00e+00 | 8.351 | 1 | 1 | 2 |
GO:0000939 | condensed chromosome inner kinetochore | 3.06e-03 | 1.00e+00 | 8.351 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 3.06e-03 | 1.00e+00 | 8.351 | 1 | 1 | 2 |
GO:0004416 | hydroxyacylglutathione hydrolase activity | 3.06e-03 | 1.00e+00 | 8.351 | 1 | 1 | 2 |
GO:0060965 | negative regulation of gene silencing by miRNA | 3.06e-03 | 1.00e+00 | 8.351 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 3.06e-03 | 1.00e+00 | 8.351 | 1 | 1 | 2 |
GO:0005684 | U2-type spliceosomal complex | 3.06e-03 | 1.00e+00 | 8.351 | 1 | 1 | 2 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 3.06e-03 | 1.00e+00 | 8.351 | 1 | 1 | 2 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 3.06e-03 | 1.00e+00 | 8.351 | 1 | 1 | 2 |
GO:0002944 | cyclin K-CDK12 complex | 3.06e-03 | 1.00e+00 | 8.351 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 3.06e-03 | 1.00e+00 | 8.351 | 1 | 1 | 2 |
GO:0003677 | DNA binding | 3.33e-03 | 1.00e+00 | 1.758 | 7 | 16 | 1351 |
GO:0000502 | proteasome complex | 3.53e-03 | 1.00e+00 | 4.493 | 2 | 2 | 58 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.72e-03 | 1.00e+00 | 2.619 | 4 | 14 | 425 |
GO:0043066 | negative regulation of apoptotic process | 3.97e-03 | 1.00e+00 | 2.592 | 4 | 5 | 433 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.42e-03 | 1.00e+00 | 4.328 | 2 | 3 | 65 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 4.42e-03 | 1.00e+00 | 4.328 | 2 | 3 | 65 |
GO:0071459 | protein localization to chromosome, centromeric region | 4.59e-03 | 1.00e+00 | 7.766 | 1 | 1 | 3 |
GO:0006458 | 'de novo' protein folding | 4.59e-03 | 1.00e+00 | 7.766 | 1 | 1 | 3 |
GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex | 4.59e-03 | 1.00e+00 | 7.766 | 1 | 1 | 3 |
GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex | 4.59e-03 | 1.00e+00 | 7.766 | 1 | 1 | 3 |
GO:0046040 | IMP metabolic process | 4.59e-03 | 1.00e+00 | 7.766 | 1 | 1 | 3 |
GO:0044208 | 'de novo' AMP biosynthetic process | 4.59e-03 | 1.00e+00 | 7.766 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 4.59e-03 | 1.00e+00 | 7.766 | 1 | 1 | 3 |
GO:0030135 | coated vesicle | 4.59e-03 | 1.00e+00 | 7.766 | 1 | 1 | 3 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.69e-03 | 1.00e+00 | 4.284 | 2 | 3 | 67 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.10e-03 | 1.00e+00 | 4.221 | 2 | 4 | 70 |
GO:0005759 | mitochondrial matrix | 5.24e-03 | 1.00e+00 | 3.071 | 3 | 4 | 233 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 5.54e-03 | 1.00e+00 | 4.161 | 2 | 2 | 73 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.69e-03 | 1.00e+00 | 4.141 | 2 | 4 | 74 |
GO:0008134 | transcription factor binding | 6.09e-03 | 1.00e+00 | 2.993 | 3 | 6 | 246 |
GO:0051716 | cellular response to stimulus | 6.11e-03 | 1.00e+00 | 7.351 | 1 | 2 | 4 |
GO:0000778 | condensed nuclear chromosome kinetochore | 6.11e-03 | 1.00e+00 | 7.351 | 1 | 1 | 4 |
GO:0006167 | AMP biosynthetic process | 6.11e-03 | 1.00e+00 | 7.351 | 1 | 1 | 4 |
GO:0060913 | cardiac cell fate determination | 6.11e-03 | 1.00e+00 | 7.351 | 1 | 1 | 4 |
GO:0003747 | translation release factor activity | 6.11e-03 | 1.00e+00 | 7.351 | 1 | 2 | 4 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 6.14e-03 | 1.00e+00 | 4.084 | 2 | 2 | 77 |
GO:0071013 | catalytic step 2 spliceosome | 6.46e-03 | 1.00e+00 | 4.047 | 2 | 3 | 79 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 6.46e-03 | 1.00e+00 | 4.047 | 2 | 4 | 79 |
GO:0001714 | endodermal cell fate specification | 7.64e-03 | 1.00e+00 | 7.029 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 7.64e-03 | 1.00e+00 | 7.029 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 7.64e-03 | 1.00e+00 | 7.029 | 1 | 2 | 5 |
GO:0005672 | transcription factor TFIIA complex | 7.64e-03 | 1.00e+00 | 7.029 | 1 | 1 | 5 |
GO:0046696 | lipopolysaccharide receptor complex | 7.64e-03 | 1.00e+00 | 7.029 | 1 | 1 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 7.64e-03 | 1.00e+00 | 7.029 | 1 | 1 | 5 |
GO:0032057 | negative regulation of translational initiation in response to stress | 7.64e-03 | 1.00e+00 | 7.029 | 1 | 1 | 5 |
GO:0000389 | mRNA 3'-splice site recognition | 7.64e-03 | 1.00e+00 | 7.029 | 1 | 1 | 5 |
GO:0043405 | regulation of MAP kinase activity | 7.64e-03 | 1.00e+00 | 7.029 | 1 | 1 | 5 |
GO:0016363 | nuclear matrix | 8.67e-03 | 1.00e+00 | 3.827 | 2 | 5 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 9.03e-03 | 1.00e+00 | 3.796 | 2 | 2 | 94 |
GO:0050847 | progesterone receptor signaling pathway | 9.16e-03 | 1.00e+00 | 6.766 | 1 | 1 | 6 |
GO:0003688 | DNA replication origin binding | 9.16e-03 | 1.00e+00 | 6.766 | 1 | 1 | 6 |
GO:0006531 | aspartate metabolic process | 9.16e-03 | 1.00e+00 | 6.766 | 1 | 1 | 6 |
GO:0060744 | mammary gland branching involved in thelarche | 9.16e-03 | 1.00e+00 | 6.766 | 1 | 1 | 6 |
GO:0050733 | RS domain binding | 9.16e-03 | 1.00e+00 | 6.766 | 1 | 1 | 6 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 9.16e-03 | 1.00e+00 | 6.766 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 9.16e-03 | 1.00e+00 | 6.766 | 1 | 2 | 6 |
GO:0005851 | eukaryotic translation initiation factor 2B complex | 9.16e-03 | 1.00e+00 | 6.766 | 1 | 3 | 6 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 9.16e-03 | 1.00e+00 | 6.766 | 1 | 1 | 6 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 9.16e-03 | 1.00e+00 | 6.766 | 1 | 1 | 6 |
GO:0001649 | osteoblast differentiation | 9.22e-03 | 1.00e+00 | 3.781 | 2 | 3 | 95 |
GO:0005743 | mitochondrial inner membrane | 1.05e-02 | 1.00e+00 | 2.707 | 3 | 3 | 300 |
GO:0051726 | regulation of cell cycle | 1.06e-02 | 1.00e+00 | 3.678 | 2 | 4 | 102 |
GO:0005730 | nucleolus | 1.11e-02 | 1.00e+00 | 1.440 | 7 | 28 | 1684 |
GO:0001055 | RNA polymerase II activity | 1.22e-02 | 1.00e+00 | 6.351 | 1 | 1 | 8 |
GO:0001955 | blood vessel maturation | 1.22e-02 | 1.00e+00 | 6.351 | 1 | 1 | 8 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 1.22e-02 | 1.00e+00 | 6.351 | 1 | 1 | 8 |
GO:0000780 | condensed nuclear chromosome, centromeric region | 1.22e-02 | 1.00e+00 | 6.351 | 1 | 1 | 8 |
GO:0016779 | nucleotidyltransferase activity | 1.22e-02 | 1.00e+00 | 6.351 | 1 | 1 | 8 |
GO:0000209 | protein polyubiquitination | 1.35e-02 | 1.00e+00 | 3.493 | 2 | 5 | 116 |
GO:0071354 | cellular response to interleukin-6 | 1.37e-02 | 1.00e+00 | 6.181 | 1 | 1 | 9 |
GO:0014850 | response to muscle activity | 1.37e-02 | 1.00e+00 | 6.181 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 1.37e-02 | 1.00e+00 | 6.181 | 1 | 1 | 9 |
GO:0043032 | positive regulation of macrophage activation | 1.52e-02 | 1.00e+00 | 6.029 | 1 | 1 | 10 |
GO:0051382 | kinetochore assembly | 1.52e-02 | 1.00e+00 | 6.029 | 1 | 1 | 10 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 1.52e-02 | 1.00e+00 | 6.029 | 1 | 2 | 10 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.52e-02 | 1.00e+00 | 6.029 | 1 | 1 | 10 |
GO:0051604 | protein maturation | 1.52e-02 | 1.00e+00 | 6.029 | 1 | 1 | 10 |
GO:0006750 | glutathione biosynthetic process | 1.52e-02 | 1.00e+00 | 6.029 | 1 | 1 | 10 |
GO:0032727 | positive regulation of interferon-alpha production | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 11 |
GO:0071257 | cellular response to electrical stimulus | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 11 |
GO:0001054 | RNA polymerase I activity | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 2 | 11 |
GO:0035413 | positive regulation of catenin import into nucleus | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 11 |
GO:0042301 | phosphate ion binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 11 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 2 | 12 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 2 | 12 |
GO:0005838 | proteasome regulatory particle | 1.82e-02 | 1.00e+00 | 5.766 | 1 | 1 | 12 |
GO:0009416 | response to light stimulus | 1.97e-02 | 1.00e+00 | 5.650 | 1 | 1 | 13 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.97e-02 | 1.00e+00 | 5.650 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 1.97e-02 | 1.00e+00 | 5.650 | 1 | 1 | 13 |
GO:0001530 | lipopolysaccharide binding | 1.97e-02 | 1.00e+00 | 5.650 | 1 | 1 | 13 |
GO:0035198 | miRNA binding | 1.97e-02 | 1.00e+00 | 5.650 | 1 | 1 | 13 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.97e-02 | 1.00e+00 | 5.650 | 1 | 1 | 13 |
GO:0071480 | cellular response to gamma radiation | 2.12e-02 | 1.00e+00 | 5.543 | 1 | 1 | 14 |
GO:0005685 | U1 snRNP | 2.12e-02 | 1.00e+00 | 5.543 | 1 | 1 | 14 |
GO:0005095 | GTPase inhibitor activity | 2.12e-02 | 1.00e+00 | 5.543 | 1 | 1 | 14 |
GO:0032465 | regulation of cytokinesis | 2.12e-02 | 1.00e+00 | 5.543 | 1 | 1 | 14 |
GO:0000278 | mitotic cell cycle | 2.22e-02 | 1.00e+00 | 2.299 | 3 | 12 | 398 |
GO:0046982 | protein heterodimerization activity | 2.24e-02 | 1.00e+00 | 2.295 | 3 | 3 | 399 |
GO:0042026 | protein refolding | 2.27e-02 | 1.00e+00 | 5.444 | 1 | 1 | 15 |
GO:0006479 | protein methylation | 2.27e-02 | 1.00e+00 | 5.444 | 1 | 2 | 15 |
GO:0001824 | blastocyst development | 2.27e-02 | 1.00e+00 | 5.444 | 1 | 1 | 15 |
GO:0060749 | mammary gland alveolus development | 2.27e-02 | 1.00e+00 | 5.444 | 1 | 1 | 15 |
GO:0006376 | mRNA splice site selection | 2.27e-02 | 1.00e+00 | 5.444 | 1 | 1 | 15 |
GO:0006974 | cellular response to DNA damage stimulus | 2.41e-02 | 1.00e+00 | 3.047 | 2 | 4 | 158 |
GO:0042176 | regulation of protein catabolic process | 2.42e-02 | 1.00e+00 | 5.351 | 1 | 1 | 16 |
GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity | 2.42e-02 | 1.00e+00 | 5.351 | 1 | 1 | 16 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 2.42e-02 | 1.00e+00 | 5.351 | 1 | 1 | 16 |
GO:0000132 | establishment of mitotic spindle orientation | 2.42e-02 | 1.00e+00 | 5.351 | 1 | 1 | 16 |
GO:0001056 | RNA polymerase III activity | 2.42e-02 | 1.00e+00 | 5.351 | 1 | 1 | 16 |
GO:0005737 | cytoplasm | 2.46e-02 | 1.00e+00 | 0.853 | 11 | 43 | 3976 |
GO:0005666 | DNA-directed RNA polymerase III complex | 2.57e-02 | 1.00e+00 | 5.263 | 1 | 1 | 17 |
GO:0050870 | positive regulation of T cell activation | 2.57e-02 | 1.00e+00 | 5.263 | 1 | 1 | 17 |
GO:0022624 | proteasome accessory complex | 2.57e-02 | 1.00e+00 | 5.263 | 1 | 1 | 17 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.62e-02 | 1.00e+00 | 2.208 | 3 | 7 | 424 |
GO:0030332 | cyclin binding | 2.72e-02 | 1.00e+00 | 5.181 | 1 | 1 | 18 |
GO:0006386 | termination of RNA polymerase III transcription | 2.72e-02 | 1.00e+00 | 5.181 | 1 | 1 | 18 |
GO:0017025 | TBP-class protein binding | 2.72e-02 | 1.00e+00 | 5.181 | 1 | 1 | 18 |
GO:0006541 | glutamine metabolic process | 2.72e-02 | 1.00e+00 | 5.181 | 1 | 1 | 18 |
GO:0070064 | proline-rich region binding | 2.72e-02 | 1.00e+00 | 5.181 | 1 | 1 | 18 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 2.72e-02 | 1.00e+00 | 5.181 | 1 | 1 | 18 |
GO:0005839 | proteasome core complex | 2.72e-02 | 1.00e+00 | 5.181 | 1 | 1 | 18 |
GO:0032733 | positive regulation of interleukin-10 production | 2.87e-02 | 1.00e+00 | 5.103 | 1 | 2 | 19 |
GO:0034641 | cellular nitrogen compound metabolic process | 2.98e-02 | 1.00e+00 | 2.883 | 2 | 3 | 177 |
GO:0007049 | cell cycle | 2.98e-02 | 1.00e+00 | 2.883 | 2 | 4 | 177 |
GO:0004298 | threonine-type endopeptidase activity | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 1 | 20 |
GO:0016597 | amino acid binding | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 1 | 20 |
GO:0014003 | oligodendrocyte development | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 3 | 20 |
GO:0003714 | transcription corepressor activity | 3.04e-02 | 1.00e+00 | 2.867 | 2 | 5 | 179 |
GO:0032757 | positive regulation of interleukin-8 production | 3.17e-02 | 1.00e+00 | 4.958 | 1 | 1 | 21 |
GO:0016575 | histone deacetylation | 3.17e-02 | 1.00e+00 | 4.958 | 1 | 1 | 21 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 22 |
GO:0043484 | regulation of RNA splicing | 3.47e-02 | 1.00e+00 | 4.827 | 1 | 1 | 23 |
GO:0008135 | translation factor activity, nucleic acid binding | 3.61e-02 | 1.00e+00 | 4.766 | 1 | 2 | 24 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 3.61e-02 | 1.00e+00 | 4.766 | 1 | 1 | 24 |
GO:0042100 | B cell proliferation | 3.76e-02 | 1.00e+00 | 4.707 | 1 | 1 | 25 |
GO:0003899 | DNA-directed RNA polymerase activity | 3.76e-02 | 1.00e+00 | 4.707 | 1 | 1 | 25 |
GO:0005844 | polysome | 3.76e-02 | 1.00e+00 | 4.707 | 1 | 2 | 25 |
GO:0042113 | B cell activation | 3.76e-02 | 1.00e+00 | 4.707 | 1 | 1 | 25 |
GO:0032735 | positive regulation of interleukin-12 production | 3.76e-02 | 1.00e+00 | 4.707 | 1 | 2 | 25 |
GO:0003924 | GTPase activity | 3.83e-02 | 1.00e+00 | 2.685 | 2 | 2 | 203 |
GO:0035329 | hippo signaling | 3.91e-02 | 1.00e+00 | 4.650 | 1 | 1 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 3.91e-02 | 1.00e+00 | 4.650 | 1 | 2 | 26 |
GO:0000188 | inactivation of MAPK activity | 4.06e-02 | 1.00e+00 | 4.596 | 1 | 1 | 27 |
GO:0001103 | RNA polymerase II repressing transcription factor binding | 4.06e-02 | 1.00e+00 | 4.596 | 1 | 1 | 27 |
GO:0034080 | CENP-A containing nucleosome assembly | 4.06e-02 | 1.00e+00 | 4.596 | 1 | 2 | 27 |
GO:0030331 | estrogen receptor binding | 4.06e-02 | 1.00e+00 | 4.596 | 1 | 2 | 27 |
GO:0071897 | DNA biosynthetic process | 4.35e-02 | 1.00e+00 | 4.493 | 1 | 1 | 29 |
GO:0006184 | GTP catabolic process | 4.43e-02 | 1.00e+00 | 2.569 | 2 | 2 | 220 |
GO:0006370 | 7-methylguanosine mRNA capping | 4.50e-02 | 1.00e+00 | 4.444 | 1 | 2 | 30 |
GO:0006360 | transcription from RNA polymerase I promoter | 4.50e-02 | 1.00e+00 | 4.444 | 1 | 1 | 30 |
GO:0016071 | mRNA metabolic process | 4.54e-02 | 1.00e+00 | 2.550 | 2 | 8 | 223 |
GO:0006144 | purine nucleobase metabolic process | 4.79e-02 | 1.00e+00 | 4.351 | 1 | 2 | 32 |
GO:0004693 | cyclin-dependent protein serine/threonine kinase activity | 4.79e-02 | 1.00e+00 | 4.351 | 1 | 1 | 32 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 4.79e-02 | 1.00e+00 | 4.351 | 1 | 1 | 32 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 3 | 33 |
GO:0003713 | transcription coactivator activity | 5.14e-02 | 1.00e+00 | 2.450 | 2 | 7 | 239 |
GO:0016592 | mediator complex | 5.23e-02 | 1.00e+00 | 4.221 | 1 | 5 | 35 |
GO:0000049 | tRNA binding | 5.37e-02 | 1.00e+00 | 4.181 | 1 | 1 | 36 |
GO:0032755 | positive regulation of interleukin-6 production | 5.37e-02 | 1.00e+00 | 4.181 | 1 | 2 | 36 |
GO:0016070 | RNA metabolic process | 5.45e-02 | 1.00e+00 | 2.402 | 2 | 8 | 247 |
GO:0002376 | immune system process | 5.52e-02 | 1.00e+00 | 4.141 | 1 | 1 | 37 |
GO:0008033 | tRNA processing | 5.81e-02 | 1.00e+00 | 4.065 | 1 | 1 | 39 |
GO:0006383 | transcription from RNA polymerase III promoter | 5.81e-02 | 1.00e+00 | 4.065 | 1 | 3 | 39 |
GO:0032729 | positive regulation of interferon-gamma production | 5.81e-02 | 1.00e+00 | 4.065 | 1 | 1 | 39 |
GO:0009408 | response to heat | 5.95e-02 | 1.00e+00 | 4.029 | 1 | 2 | 40 |
GO:0035019 | somatic stem cell maintenance | 5.95e-02 | 1.00e+00 | 4.029 | 1 | 2 | 40 |
GO:0006418 | tRNA aminoacylation for protein translation | 6.24e-02 | 1.00e+00 | 3.958 | 1 | 3 | 42 |
GO:0042110 | T cell activation | 6.39e-02 | 1.00e+00 | 3.924 | 1 | 2 | 43 |
GO:0050434 | positive regulation of viral transcription | 6.53e-02 | 1.00e+00 | 3.891 | 1 | 2 | 44 |
GO:0043525 | positive regulation of neuron apoptotic process | 6.82e-02 | 1.00e+00 | 3.827 | 1 | 2 | 46 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 6.82e-02 | 1.00e+00 | 3.827 | 1 | 1 | 46 |
GO:0043434 | response to peptide hormone | 6.82e-02 | 1.00e+00 | 3.827 | 1 | 2 | 46 |
GO:0003743 | translation initiation factor activity | 7.25e-02 | 1.00e+00 | 3.736 | 1 | 5 | 49 |
GO:0005739 | mitochondrion | 7.25e-02 | 1.00e+00 | 1.320 | 4 | 16 | 1046 |
GO:0035690 | cellular response to drug | 7.39e-02 | 1.00e+00 | 3.707 | 1 | 2 | 50 |
GO:0005905 | coated pit | 7.53e-02 | 1.00e+00 | 3.678 | 1 | 1 | 51 |
GO:0000910 | cytokinesis | 7.53e-02 | 1.00e+00 | 3.678 | 1 | 1 | 51 |
GO:0007254 | JNK cascade | 7.53e-02 | 1.00e+00 | 3.678 | 1 | 2 | 51 |
GO:0043234 | protein complex | 7.66e-02 | 1.00e+00 | 2.122 | 2 | 4 | 300 |
GO:0000775 | chromosome, centromeric region | 7.67e-02 | 1.00e+00 | 3.650 | 1 | 3 | 52 |
GO:0034976 | response to endoplasmic reticulum stress | 7.67e-02 | 1.00e+00 | 3.650 | 1 | 1 | 52 |
GO:0045454 | cell redox homeostasis | 7.67e-02 | 1.00e+00 | 3.650 | 1 | 1 | 52 |
GO:0009611 | response to wounding | 7.82e-02 | 1.00e+00 | 3.623 | 1 | 1 | 53 |
GO:0003725 | double-stranded RNA binding | 7.96e-02 | 1.00e+00 | 3.596 | 1 | 1 | 54 |
GO:0000226 | microtubule cytoskeleton organization | 8.10e-02 | 1.00e+00 | 3.569 | 1 | 2 | 55 |
GO:0002039 | p53 binding | 8.10e-02 | 1.00e+00 | 3.569 | 1 | 3 | 55 |
GO:0006355 | regulation of transcription, DNA-templated | 8.48e-02 | 1.00e+00 | 1.242 | 4 | 13 | 1104 |
GO:0051087 | chaperone binding | 8.66e-02 | 1.00e+00 | 3.468 | 1 | 1 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 8.66e-02 | 1.00e+00 | 3.468 | 1 | 2 | 59 |
GO:0006396 | RNA processing | 8.80e-02 | 1.00e+00 | 3.444 | 1 | 4 | 60 |
GO:0005525 | GTP binding | 8.93e-02 | 1.00e+00 | 1.993 | 2 | 5 | 328 |
GO:0032481 | positive regulation of type I interferon production | 8.94e-02 | 1.00e+00 | 3.420 | 1 | 2 | 61 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 9.08e-02 | 1.00e+00 | 3.396 | 1 | 2 | 62 |
GO:0009749 | response to glucose | 9.36e-02 | 1.00e+00 | 3.351 | 1 | 2 | 64 |
GO:0030141 | secretory granule | 9.78e-02 | 1.00e+00 | 3.284 | 1 | 1 | 67 |
GO:0006289 | nucleotide-excision repair | 1.01e-01 | 1.00e+00 | 3.242 | 1 | 1 | 69 |
GO:0003697 | single-stranded DNA binding | 1.01e-01 | 1.00e+00 | 3.242 | 1 | 2 | 69 |
GO:0000786 | nucleosome | 1.02e-01 | 1.00e+00 | 3.221 | 1 | 1 | 70 |
GO:0010468 | regulation of gene expression | 1.05e-01 | 1.00e+00 | 3.181 | 1 | 1 | 72 |
GO:0003729 | mRNA binding | 1.06e-01 | 1.00e+00 | 3.161 | 1 | 3 | 73 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 1.06e-01 | 1.00e+00 | 3.161 | 1 | 2 | 73 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 1.07e-01 | 1.00e+00 | 3.141 | 1 | 2 | 74 |
GO:0042826 | histone deacetylase binding | 1.07e-01 | 1.00e+00 | 3.141 | 1 | 2 | 74 |
GO:0043565 | sequence-specific DNA binding | 1.07e-01 | 1.00e+00 | 1.839 | 2 | 3 | 365 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 1.10e-01 | 1.00e+00 | 3.103 | 1 | 2 | 76 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 1.12e-01 | 1.00e+00 | 3.084 | 1 | 2 | 77 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 1.12e-01 | 1.00e+00 | 3.084 | 1 | 2 | 77 |
GO:0006334 | nucleosome assembly | 1.14e-01 | 1.00e+00 | 3.047 | 1 | 3 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 1.16e-01 | 1.00e+00 | 3.029 | 1 | 3 | 80 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.17e-01 | 1.00e+00 | 3.011 | 1 | 2 | 81 |
GO:0051301 | cell division | 1.17e-01 | 1.00e+00 | 3.011 | 1 | 2 | 81 |
GO:0005681 | spliceosomal complex | 1.20e-01 | 1.00e+00 | 2.976 | 1 | 1 | 83 |
GO:0016020 | membrane | 1.22e-01 | 1.00e+00 | 0.903 | 5 | 27 | 1746 |
GO:0009653 | anatomical structure morphogenesis | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 1 | 87 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.25e-01 | 1.00e+00 | 1.272 | 3 | 13 | 811 |
GO:0006415 | translational termination | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 2 | 87 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 1.27e-01 | 1.00e+00 | 2.891 | 1 | 4 | 88 |
GO:0050821 | protein stabilization | 1.31e-01 | 1.00e+00 | 2.843 | 1 | 3 | 91 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 1.33e-01 | 1.00e+00 | 2.811 | 1 | 2 | 93 |
GO:0005770 | late endosome | 1.35e-01 | 1.00e+00 | 2.796 | 1 | 1 | 94 |
GO:0051082 | unfolded protein binding | 1.36e-01 | 1.00e+00 | 2.781 | 1 | 3 | 95 |
GO:0009986 | cell surface | 1.36e-01 | 1.00e+00 | 1.629 | 2 | 4 | 422 |
GO:0007010 | cytoskeleton organization | 1.37e-01 | 1.00e+00 | 2.766 | 1 | 1 | 96 |
GO:0051015 | actin filament binding | 1.39e-01 | 1.00e+00 | 2.751 | 1 | 1 | 97 |
GO:0005524 | ATP binding | 1.49e-01 | 1.00e+00 | 0.948 | 4 | 13 | 1354 |
GO:0008360 | regulation of cell shape | 1.50e-01 | 1.00e+00 | 2.623 | 1 | 1 | 106 |
GO:0015630 | microtubule cytoskeleton | 1.58e-01 | 1.00e+00 | 2.543 | 1 | 1 | 112 |
GO:0030308 | negative regulation of cell growth | 1.60e-01 | 1.00e+00 | 2.530 | 1 | 2 | 113 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.61e-01 | 1.00e+00 | 2.518 | 1 | 3 | 114 |
GO:0030529 | ribonucleoprotein complex | 1.61e-01 | 1.00e+00 | 2.518 | 1 | 6 | 114 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.70e-01 | 1.00e+00 | 1.423 | 2 | 6 | 487 |
GO:0003676 | nucleic acid binding | 1.71e-01 | 1.00e+00 | 2.420 | 1 | 2 | 122 |
GO:0044267 | cellular protein metabolic process | 1.75e-01 | 1.00e+00 | 1.399 | 2 | 7 | 495 |
GO:0007050 | cell cycle arrest | 1.76e-01 | 1.00e+00 | 2.373 | 1 | 3 | 126 |
GO:0070062 | extracellular vesicular exosome | 1.77e-01 | 1.00e+00 | 0.639 | 6 | 15 | 2516 |
GO:0006413 | translational initiation | 1.83e-01 | 1.00e+00 | 2.317 | 1 | 4 | 131 |
GO:0016477 | cell migration | 1.83e-01 | 1.00e+00 | 2.317 | 1 | 2 | 131 |
GO:0016055 | Wnt signaling pathway | 1.95e-01 | 1.00e+00 | 2.211 | 1 | 3 | 141 |
GO:0016887 | ATPase activity | 1.99e-01 | 1.00e+00 | 2.181 | 1 | 1 | 144 |
GO:0005769 | early endosome | 2.16e-01 | 1.00e+00 | 2.047 | 1 | 1 | 158 |
GO:0046777 | protein autophosphorylation | 2.16e-01 | 1.00e+00 | 2.047 | 1 | 3 | 158 |
GO:0006915 | apoptotic process | 2.17e-01 | 1.00e+00 | 1.193 | 2 | 8 | 571 |
GO:0000287 | magnesium ion binding | 2.35e-01 | 1.00e+00 | 1.908 | 1 | 2 | 174 |
GO:0004672 | protein kinase activity | 2.40e-01 | 1.00e+00 | 1.875 | 1 | 1 | 178 |
GO:0005667 | transcription factor complex | 2.40e-01 | 1.00e+00 | 1.875 | 1 | 3 | 178 |
GO:0031625 | ubiquitin protein ligase binding | 2.42e-01 | 1.00e+00 | 1.859 | 1 | 2 | 180 |
GO:0042803 | protein homodimerization activity | 2.44e-01 | 1.00e+00 | 1.081 | 2 | 6 | 617 |
GO:0043547 | positive regulation of GTPase activity | 2.54e-01 | 1.00e+00 | 1.781 | 1 | 2 | 190 |
GO:0001701 | in utero embryonic development | 2.77e-01 | 1.00e+00 | 1.636 | 1 | 2 | 210 |
GO:0005622 | intracellular | 2.95e-01 | 1.00e+00 | 1.530 | 1 | 2 | 226 |
GO:0006412 | translation | 3.04e-01 | 1.00e+00 | 1.474 | 1 | 5 | 235 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.19e-01 | 1.00e+00 | 0.804 | 2 | 10 | 748 |
GO:0044281 | small molecule metabolic process | 3.19e-01 | 1.00e+00 | 0.597 | 3 | 12 | 1295 |
GO:0006281 | DNA repair | 3.35e-01 | 1.00e+00 | 1.306 | 1 | 4 | 264 |
GO:0043065 | positive regulation of apoptotic process | 3.45e-01 | 1.00e+00 | 1.253 | 1 | 3 | 274 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 3.46e-01 | 1.00e+00 | 1.247 | 1 | 4 | 275 |
GO:0019899 | enzyme binding | 3.59e-01 | 1.00e+00 | 1.181 | 1 | 3 | 288 |
GO:0006200 | ATP catabolic process | 3.74e-01 | 1.00e+00 | 1.107 | 1 | 1 | 303 |
GO:0008283 | cell proliferation | 4.01e-01 | 1.00e+00 | 0.980 | 1 | 3 | 331 |
GO:0003682 | chromatin binding | 4.04e-01 | 1.00e+00 | 0.967 | 1 | 7 | 334 |
GO:0005813 | centrosome | 4.09e-01 | 1.00e+00 | 0.945 | 1 | 4 | 339 |
GO:0030054 | cell junction | 4.24e-01 | 1.00e+00 | 0.875 | 1 | 3 | 356 |
GO:0007165 | signal transduction | 4.32e-01 | 1.00e+00 | 0.459 | 2 | 8 | 950 |
GO:0008285 | negative regulation of cell proliferation | 4.34e-01 | 1.00e+00 | 0.831 | 1 | 4 | 367 |
GO:0005925 | focal adhesion | 4.37e-01 | 1.00e+00 | 0.819 | 1 | 2 | 370 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 6.01e-01 | 1.00e+00 | 0.148 | 1 | 10 | 589 |
GO:0045087 | innate immune response | 6.18e-01 | 1.00e+00 | 0.084 | 1 | 4 | 616 |
GO:0005887 | integral component of plasma membrane | 7.81e-01 | 1.00e+00 | -0.558 | 1 | 1 | 961 |
GO:0005615 | extracellular space | 7.98e-01 | 1.00e+00 | -0.630 | 1 | 4 | 1010 |
GO:0005576 | extracellular region | 8.10e-01 | 1.00e+00 | -0.684 | 1 | 1 | 1049 |
GO:0008270 | zinc ion binding | 8.16e-01 | 1.00e+00 | -0.709 | 1 | 11 | 1067 |
GO:0005886 | plasma membrane | 8.35e-01 | 1.00e+00 | -0.533 | 3 | 14 | 2834 |
GO:0046872 | metal ion binding | 9.05e-01 | 1.00e+00 | -1.166 | 1 | 6 | 1465 |
GO:0006351 | transcription, DNA-templated | 9.22e-01 | 1.00e+00 | -1.280 | 1 | 17 | 1585 |